Skip to main content
Intermediate Technical In the Industry Vocabulary Test

liquid biopsy

A blood-based test that detects circulating tumor cells or tumor-derived genetic material.

Full Definition

Liquid biopsy is a minimally invasive diagnostic approach that analyzes circulating tumor cells (CTCs), circulating tumor DNA (ctDNA), or other tumor-derived materials in blood or other body fluids. This technology enables real-time monitoring of tumor genetics, treatment response, and disease progression without requiring invasive tissue biopsies. Liquid biopsy applications include early cancer detection, treatment selection, resistance monitoring, and minimal residual disease assessment, though sensitivity and specificity vary by cancer type and disease stage.

Usage

Usage note: Results interpretation requires understanding of detection limits and clinical validation status.

In Context

  • "Liquid biopsy results showed the emergence of resistance mutations during targeted therapy treatment." — Clinical report
  • "The oncologist ordered liquid biopsy testing to monitor treatment response without requiring repeat tissue sampling." — Medical documentation

Also known as

circulating tumor DNA testing ctDNA analysis blood-based biopsy

Contrasted with

tissue biopsy solid biopsy

Don't confuse with

serum biomarker circulating biomarker

Editors from these organizations have used our services since 1998

Reuters BBC Oxford University Press Penguin Random House Springer Microsoft Suncor Energy United Nations Fisher Investments IBM The Home Depot KODAK CHEVRON